drugset / Trial / NCT01216046
Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the pharmacokinetics and safety of VX-809 and VX-770 alone and in combination in healthy subjects.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivacaftor | Other / unclassified | — | Oral |
| Subject | Lumacaftor | Small molecule | — | Oral |